Jiangsu Bioperfectus Technologies Co Ltd (688399) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Jiangsu Bioperfectus Technologies Co Ltd (688399) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.00 Million ≈ $2.93 Million USD) by net assets (CN¥2.97 Billion ≈ $434.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Jiangsu Bioperfectus Technologies Co Ltd worth for the company's overall valuation and market capitalisation.

Jiangsu Bioperfectus Technologies Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Jiangsu Bioperfectus Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Bioperfectus Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Bioperfectus Technologies Co Ltd ranked by their cash flow conversion efficiency. Explore Jiangsu Bioperfectus Technologies Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Lands’ End Inc NASDAQ:LE	-0.148x
Balmer Lawrie & Company Limited NSE:BALMLAWRIE	-0.035x
Horizon Technology Finance NASDAQ:HRZN	0.029x
Biofarm Bucure RO:BIO	0.052x
Shanghai Lisheng Racing Co Ltd SHE:002858	0.012x
Shenke Slide Bearing Corp SHE:002633	0.031x
Beijing Fjr Optoelectronic Technology Co Ltd SHG:688272	-0.043x
Shenzhen New Land Co Ltd SHE:300778	0.003x

Annual Cash Flow Conversion Efficiency for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. View current stock price of Jiangsu Bioperfectus Technologies Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.25 Billion ≈ $475.67 Million	CN¥145.93 Million ≈ $21.35 Million	0.045x	+235.10%
2023-12-31	CN¥3.41 Billion ≈ $498.27 Million	CN¥-113.14 Million ≈ $-16.56 Million	-0.033x	-106.39%
2022-12-31	CN¥3.78 Billion ≈ $552.86 Million	CN¥1.96 Billion ≈ $287.52 Million	0.520x	+33.85%
2021-12-31	CN¥2.54 Billion ≈ $371.16 Million	CN¥985.52 Million ≈ $144.21 Million	0.389x	-30.90%
2020-12-31	CN¥1.66 Billion ≈ $243.57 Million	CN¥935.88 Million ≈ $136.95 Million	0.562x	+437.82%
2019-12-31	CN¥1.02 Billion ≈ $149.37 Million	CN¥106.72 Million ≈ $15.62 Million	0.105x	-60.52%
2018-12-31	CN¥324.10 Million ≈ $47.43 Million	CN¥85.82 Million ≈ $12.56 Million	0.265x	+11.90%
2017-12-31	CN¥260.28 Million ≈ $38.09 Million	CN¥61.59 Million ≈ $9.01 Million	0.237x	+169.80%
2016-12-31	CN¥251.90 Million ≈ $36.86 Million	CN¥22.09 Million ≈ $3.23 Million	0.088x	--

About Jiangsu Bioperfectus Technologies Co Ltd

SHG:688399 China Biotechnology

Market Cap

$309.53 Million

CN¥2.12 Billion CNY

Market Cap Rank

#14787 Global

#4419 in China

Share Price

CN¥25.22

Change (1 day)

+1.73%

52-Week Range

CN¥23.79 - CN¥84.90

All Time High

CN¥419.88